Almirall develops pharmaceutical solutions for medical dermatology. Since 1944, the Barcelona based company has researched treatments for psoriasis, actinic keratosis, atopic dermatitis, acne, and rare skin diseases. Almirall collaborates with scientists and healthcare professionals to bring medicines to patients in over 100 countries. The company addresses unmet medical needs through proprietary research and partnerships. Patients with chronic skin conditions benefit from treatments that enable them to reconnect with daily life. By pairing scientific rigour with understanding of how diseases affect physical and emotional wellbeing, Almirall transforms outcomes for people seeking dermatological care.
2108
Team Members
1944
Founded
Pharma
Sector
Hybrid
Work Environment
A world where people living with skin conditions can achieve full physical and emotional wellbeing, free from the limitations these diseases impose on their daily lives, relationships, and self-esteem.
Almirall partners with healthcare professionals and scientists to develop innovative medical dermatology treatments that transform the lives of patients with skin diseases, enabling them to reconnect with daily living.